Literature DB >> 21553228

Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.

Young Ho Lee1, Sang-Cheol Bae, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

The aim of this study was to determine whether the interleukin-10 (IL-10) polymorphisms confer susceptibility to rheumatoid arthritis (RA). A meta-analysis was conducted on the associations between the IL-10 -1082 G/A, -592 C/A, -892 C/T and IL-10.R polymorphisms and RA using; (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) the additive model. A total of 16 studies (19 comparisons) involving 2647 RA patients and 3383 controls were considered in the meta-analysis. Meta-analysis of the IL-10 -1082 G/A polymorphism showed no association with RA in the study subjects, or in European or Asian subjects. However, meta-analysis of the -1082 G allele in 4 studies in Hardy-Weinberg equilibrium showed a significant association with RA (OR=1.217, 95% CI=1.027-1.442, P=0.0236). In contrast, meta-analysis of the C allele, the CC genotype, and of the CC versus the AA genotype of the IL-10 -592 C/A polymorphism showed significant associations with RA. The overall ORs of the associations between the C allele and RA were 0.684 and 0.758 (95% CI=0.494-0.946, P=0.022; 95% CI=0.475-1.210, P=0.045) in all study subjects and Asians. Meta-analysis of the CC+CT versus TT genotype and of the CC versus TT genotype of the IL-10 -892 C/T polymorphism revealed significant associations with RA. The overall OR of the association between the C allele carrier and RA was 0.552 (95% CI=0.375-0.812, P=0.003). No association was found between the IL10.R2 alleles and RA. This meta-analysis suggests that the IL-10 -592 C/A polymorphism confers susceptibility to RA in Asians and that the IL-10 -1082 G/A and -892 C/T polymorphisms are associated with RA susceptibility. These findings suggest the IL-10 genes confer susceptibility to RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553228     DOI: 10.1007/s11033-011-0712-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

3.  Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome.

Authors:  G Coakley; C C Mok; A H Hajeer; W E Ollier; D Turner; P J Sinnott; I V Hutchinson; G S Panayi; J S Lanchbury
Journal:  Br J Rheumatol       Date:  1998-09

4.  Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus.

Authors:  J Eskdale; P Wordsworth; S Bowman; M Field; G Gallagher
Journal:  Tissue Antigens       Date:  1997-06

Review 5.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

6.  Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography.

Authors:  Dorothy Guzowski; Alamelu Chandrasekaran; Craig Gawel; Jacqueline Palma; Jonathan Koenig; Xue Ping Wang; Michael Dosik; Mark Kaplan; Charles C Chu; Sangeeta Chavan; Richard Furie; Emilia Albesiano; Nicholas Chiorazzi; Leslie Goodwin
Journal:  J Biomol Tech       Date:  2005-06

7.  Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.

Authors:  Banesa de Paz; Mercedes Alperi-López; Francisco J Ballina-García; Catuxa Prado; Lourdes Mozo; Carmen Gutiérrez; Ana Suárez
Journal:  J Rheumatol       Date:  2010-01-15       Impact factor: 4.666

8.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes.

Authors:  J Eskdale; G Gallagher; C L Verweij; V Keijsers; R G Westendorp; T W Huizinga
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients.

Authors:  Omer Ates; Gulen Hatemi; Vedat Hamuryudan; Aysegul Topal-Sarikaya
Journal:  Clin Rheumatol       Date:  2008-04-22       Impact factor: 2.980

10.  Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations.

Authors:  K MacKay; A Milicic; D Lee; M Tikly; S Laval; J Shatford; P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

View more
  11 in total

1.  Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children.

Authors:  T P Velavan; Birgül Büyükyazici; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2011-08-04       Impact factor: 2.846

2.  Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

Review 3.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

4.  Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression.

Authors:  Qingqing Liu; Jin Yang; Hairong He; Yong Yu; Jun Lyu
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

5.  Oral treatment with Hev b 13 prevents experimental arthritis in mice.

Authors:  Larissa De Bortoli Teixeira; Vera Lúcia Aparecida Aguillar Epifânio; João José Lachat; Norma Tiraboschi Foss; Joaquim Coutinho-Netto
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

6.  Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis.

Authors:  C Ciccacci; P Conigliaro; C Perricone; S Rufini; P Triggianese; C Politi; G Novelli; R Perricone; P Borgiani
Journal:  Clin Exp Immunol       Date:  2016-08-02       Impact factor: 4.330

7.  Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2021-05       Impact factor: 1.372

Review 8.  Pathologic patterns of interleukin 10 expression--a review.

Authors:  Jasenka Trifunović; Larisa Miller; Željko Debeljak; Vesna Horvat
Journal:  Biochem Med (Zagreb)       Date:  2015       Impact factor: 2.313

9.  Interleukin-10 promoter gene polymorphisms and susceptibility to asthma: a meta-analysis.

Authors:  Myung-Han Hyun; Chung-Ho Lee; Min-Hyung Kang; Bong-Kyung Park; Young Ho Lee
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Polymorphisms of Pre-miR-499 rs3746444 T/C and Pre-miR-146a rs2910164 C/G in the Autoimmune Diseases of Rheumatoid Arthritis and Systemic Lupus Erythematosus in the West of Iran.

Authors:  Kolsoum Ahmadi; Azam Soleimani; Shadi Soleimani Motlagh; Shahram Baharvand Ahmadi; Mohammad Almasian; Ali Asghar Kiani
Journal:  Iran J Public Health       Date:  2020-04       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.